| Income Statement for Regeneron Pharmaceuticals Inc. (REGN) | | | | | | | Income | in Thousands of Dollars | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Operating Revenue | 125,024 | 63,447 | 66,193 | 174,017 | 57,497 | | Adjustments to Revenue | - | - | - | - | - | | Cost of Revenue | 11,487 | 6,446 | 5,947 | 148 | 6,261 | | Gross Operating Profit | 136,511 | 69,893 | 72,140 | 174,165 | 63,758 | | | Selling/General/Admin Expense | (37,865) | (25,892) | (25,476) | (17,062) | (14,785) | | Research & Development | (201,613) | (137,064) | (155,581) | (136,095) | (136,024) | | EBITDA | (102,967) | (93,063) | (108,917) | 21,008 | (87,051) | | Depreciation & Amortization | (11,487) | (14,592) | (15,504) | (15,362) | (12,937) | | EBIT | (114,454) | (107,655) | (124,421) | 5,646 | (99,988) | | Interest Income | - | - | - | - | - | | Other Income, Net | 20,897 | 16,548 | 41,021 | 48,228 | 4,462 | | Total Income Avail For Interest Expense | (93,557) | (91,107) | (83,400) | 53,874 | (95,526) | | Interest Expense | (12,043) | (12,043) | (12,046) | (12,175) | (11,932) | | Pre-Tax Income | (105,600) | (103,150) | (95,446) | 41,699 | (107,458) | | Income Taxes | - | - | - | - | - | | Minority Interest | - | - | - | - | - | | Net Income from Continuing Operations | (105,600) | (103,150) | (95,446) | 41,699 | (107,458) | | Net Income from Discontinued Operations | - | - | - | - | - | | Net Income from Total Operations | (105,600) | (103,150) | (95,446) | 41,699 | (107,458) | | | Normalized Income | (105,600) | (103,150) | (95,446) | 41,699 | (107,458) | | Extraordinary Income | - | - | - | - | - | | Special Income/Charges | - | - | - | - | - | | Income from Cum. Effect of Acct Change | - | 813 | - | - | - | | Income from Tax Loss Carryforward | - | - | - | - | - | | Other Gains | - | - | - | - | - | | Total Net Income | (105,600) | (102,337) | (95,446) | 41,699 | (107,458) | | | Results | in Dollars (Preferred Dividends in Thousands) | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Dividends Paid Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Preferred Dividends | - | - | - | - | - | | | Basic EPS from Continuing Operations | -1.59 | -1.78 | -1.71 | 0.75 | -2.13 | | Basic EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Basic EPS from Total Operations | -1.59 | -1.78 | -1.71 | 0.75 | -2.13 | | | Diluted EPS from Continuing Operations | -1.59 | -1.78 | -1.71 | 0.74 | -2.13 | | Diluted EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Diluted EPS from Total Operations | -1.59 | -1.78 | -1.71 | 0.74 | -2.13 | | | |
